At a glance
- Palmitoyl tetrapeptide-7 (pal-GQPR, sold as Rigin) is a signal peptide added to anti-aging products for its calming, anti-inflammatory angle.
- It is thought to dampen the low-grade inflammation that contributes to collagen breakdown over time, which is a different mechanism from collagen-building peptides.
- It is most often sold paired with palmitoyl tripeptide-1 in the blend called Matrixyl 3000.
- Human evidence for the peptide on its own is thin, and the clearest clinical data come from combination formulas.
- Evidence strength: Limited, mostly manufacturer and combination-product data rather than standalone trials.
What is palmitoyl tetrapeptide-7?
Palmitoyl tetrapeptide-7 is a four-amino-acid peptide (glycyl-glutaminyl-prolyl-arginine) with a palmitic acid chain attached, marketed under names such as Rigin. Like other palmitoylated peptides, the fatty tail is meant to help it cross the skin barrier. It is classed as a signal peptide, and it is most familiar as half of the Matrixyl 3000 blend, where it sits alongside palmitoyl tripeptide-1.
What skin type is palmitoyl tetrapeptide-7 best for?
Because its proposed role is soothing and anti-inflammatory, it is pitched at aging skin that also looks stressed or reactive, and it suits most skin types, including sensitive skin. It is not a treatment for acne, pigmentation, or deep wrinkles.
What does palmitoyl tetrapeptide-7 do?
It is reported to reduce the skin's production of interleukin-6, a messenger involved in inflammation, which in theory slows the chronic, low-level inflammation that degrades collagen as skin ages.
This anti-inflammatory angle is why it is combined with collagen-signaling peptides rather than used alone. In a 12-week controlled eye-cream trial that included palmitoyl tetrapeptide-7 with palmityl tripeptide-1 and other actives, the finished product improved elasticity, hydration, and collagen density, though the individual peptide's share of that result cannot be separated out.
How do you know if palmitoyl tetrapeptide-7 can help your skin?
It is best suited to someone looking for gradual, supportive anti-aging benefit rather than a single hero ingredient, and it is realistic to expect subtle results over two to three months. If your priority is a measurable change in established wrinkles, a retinoid has far stronger evidence.
How do you use palmitoyl tetrapeptide-7?
Apply once or twice daily to clean skin, usually in a serum or cream, and follow with moisturizer and daily sunscreen. As with other peptides, steady use over weeks matters more than quantity.
What should you use with palmitoyl tetrapeptide-7?
It is designed to work with other peptides, and its natural partner is palmitoyl tripeptide-1 in Matrixyl 3000. It also sits comfortably with hyaluronic acid, niacinamide, and ceramides. Broad-spectrum sunscreen each morning does the most to protect the collagen these peptides aim to preserve.
Evidence strength
Limited: Palmitoyl tetrapeptide-7 has a plausible anti-inflammatory mechanism, but published, independent human trials of the peptide on its own are scarce, and much of the supporting data is held by ingredient manufacturers. The clearest clinical evidence comes from multi-ingredient products in which it is one of several actives, so its specific contribution is uncertain. It is reasonable as part of a well-formulated product, but it should not be expected to carry a routine by itself.
















